This is the authors' abstract. We don't add key points for this paper.
In recent years, there have been a number of technological breakthroughs that have allowed for clinical trials in gene therapy to be initiated. In combination with the genome initiative, the potential for new therapeutics is limitless. Although an enormous amount of information has been obtained in a relatively short period of time, gene therapy is not yet ready for wide-scale practice. Some of the successes and obstacles that remain are summarized in this report.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Kay et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: